Feb 11, 2026 08:22PM

Feb 11, 2026 06:45AM

Feb 11, 2026 06:45AM

Feb 11, 2026 06:45AM

Sep 22, 2025 09:01AM

Sep 22, 2025 09:00AM

Aug 20, 2025 08:00AM Agilent receives FDA approval for colorectal cancer diagnostic test

Aug 20, 2025 08:00AM

Mar 24, 2025 08:05AM

Mar 24, 2025 08:00AM

Mar 10, 2025 08:19AM

Mar 10, 2025 08:19AM

Nov 20, 2024 08:00AM

Sep 9, 2024 08:02AM Agilent Technologies (A) Unveils Biopharma CDx Services Lab to Accelerate Precision Medicine

Sep 9, 2024 08:00AM

Aug 2, 2024 08:00AM

Aug 2, 2024 08:00AM

Jun 3, 2024 11:00AM

Jun 3, 2024 11:00AM

Nov 14, 2023 08:01AM

Nov 14, 2023 08:00AM Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Aug 24, 2023 08:00AM

Aug 24, 2023 08:00AM

Jun 6, 2023 08:00AM

Mar 10, 2023 08:00AM

Feb 9, 2023 08:00AM

Jan 23, 2023 08:00AM

Dec 12, 2022 08:50PM Agilent Resolution ctDx FIRST Receives FDA Approval as a Liquid Biopsy Companion Diagnostic Test for Advanced Non-small Cell Lung Cancer

Jul 5, 2022 08:02AM

Jul 5, 2022 08:00AM

May 25, 2022 09:14AM

Dec 6, 2021 08:00AM

Nov 23, 2021 09:05AM

Oct 13, 2021 04:16PM

Oct 13, 2021 04:16PM Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer

Jul 27, 2021 08:00AM

Jun 4, 2021 08:00AM

May 26, 2021 09:23AM

Mar 9, 2021 08:00AM

Mar 9, 2021 02:57AM

Mar 2, 2021 08:00AM

Mar 2, 2021 08:00AM Agilent to Acquire Resolution Bioscience, Strengthening Leadership Position in Cancer Diagnostics

Feb 22, 2021 01:46PM

Feb 18, 2021 08:02AM

Feb 18, 2021 08:00AM

Jan 25, 2021 08:00AM

Nov 23, 2020 05:23PM

Nov 17, 2020 08:32AM

Nov 13, 2020 08:26PM Agilent Receives Expanded FDA Approval for PD-L1 IHC 22C3 pharmDx in Triple-Negative Breast Cancer

Oct 1, 2020 02:43AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All